One Indian pharmaceutical firm’s nighttime document-shredding and potential manufacturing lapses at two others since December are reigniting concerns that, despite recent efforts, the country’s generic-drug industry still has a way to go to gain the trust ... The Financial Chronicle, 1 month ago
Posted by Equitymaster After opening the day in the green, the Indian share markets have continued to trade strong and are currently trading above the dotted line. With the exception of stocks in the FMCG sector all sectoral indices are trading on a positive ...Equitymaster.com, 4 weeks ago
Suit alleges fraud by hiding significant deficiencies in CGMP regulations enforced by US health regulator. Seoul-based biotech company Mezzion Pharma has filed a suit against Dr Reddy’s Laboratories in a US court. It has alleged the Hyderabad-based supplier had committed fraud by hiding significant deficiencies in the Current Good Manufacturing Practice, or CGMP, regulations enforced by the US health regulator. In the suit, filed in the state of New Jersey, Mezzion seeks to “recover ...Rediff.com, 4 weeks ago
on your WebpageAdd Widget >Get your members hooked!